We therefore can speculate a mechanism by which autoantibodies against TCERG1 and DDX24 might exert a pathogenetic role in MS inducing or sustaining neurodegeneration by impairing the functions of their target proteins either inducing misplacement or blocking their activity. This evidence concerns the gene TCERG1 and myeloid sarcoma.